ArticlePathogens (Basel, Switzerland)2025
A Simple Deterministic Model of Protection and Cost Benefits from Vaccinating Indian Cattle Against Infectious Bovine Rhinotracheitis.
Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Infectious Bovine Rhinotracheitis (IBR) is endemic in India, causing significant losses to dairy enterprises. Until recently, the unavailability of an indigenously manufactured vaccine and the high cost of imported vaccines limited national vaccination efforts. However, an indigenously developed and manufactured inactivated DIVA vaccine has now become available. The exact strategies that other countries have employed for the successful control of IBR may not be applicable in India due to the differences in the production systems and the social values. Hence, we have employed linear deterministic modeling to study the benefits, both in terms of the protection of the animals from the disease and the costs, of vaccination against IBR towards proposing an optimal strategy for immunization-based control of the disease in India. Our findings emphasize the need for proper vaccination practices, appropriate farm biosecurity measures, and biannual re-vaccinations to achieve the desired endpoints in a vaccination program. Based on our findings, a vaccination program aiming for primary vaccination with two doses followed by continuing bi-annual re-vaccination with a single dose to achieve 70% vaccination coverage in the cattle population can be recommended for the control of IBR in India.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.